<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?DTDIdentifier.IdentifierValue -//CJSMOD//DTD CADMUS DOCUMENT using modules//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName cjsmod.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName cjs2nlm.xsl?><?ConverterInfo.Version 1?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">FASEB J</journal-id><journal-title>The FASEB Journal</journal-title><issn pub-type="ppub">0892-6638</issn><issn pub-type="epub">1530-6860</issn><publisher><publisher-name>The Federation of American Societies for Experimental Biology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-111914</article-id><article-id pub-id-type="doi">10.1096/fj.08-111914</article-id><article-id pub-id-type="pmid">18697839</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Communications</subject></subj-group></article-categories><title-group><article-title>Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Michailidou</surname><given-names>Z.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Carter</surname><given-names>R. N.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Marshall</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Sutherland</surname><given-names>H. G.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Brownstein</surname><given-names>D. G.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Owen</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Cockett</surname><given-names>K.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Kelly</surname><given-names>V.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Ramage</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Al-Dujaili</surname><given-names>E. A. S.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Ross</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Maraki</surname><given-names>I.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Newton</surname><given-names>K.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Holmes</surname><given-names>M. C.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Seckl</surname><given-names>J. R.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Morton</surname><given-names>N. M.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Kenyon</surname><given-names>C. J.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Chapman</surname><given-names>K. E.</given-names></name><xref ref-type="aff" rid="N0x1cca570N0x1a8cc68">&#x0002a;</xref><xref rid="C1" ref-type="corresp"><sup>1</sup></xref></contrib><aff id="N0x1cca570N0x1a8cc68"><label>&#x0002a;</label>Centre for Cardiovascular Sciences, Queen&#x02019;s Medical Research, Institute, University of Edinburgh, Edinburgh, UK;</aff><aff id="N0x1cca570N0x1a8ccf8"><label>&#x02020;</label>Medical Research Council Human Genetics Unit, Edinburgh, UK; and</aff><aff id="N0x1cca570N0x1a8cd88"><label>&#x02021;</label>Queen Margaret University, Musselburgh, East Lothian, UK</aff></contrib-group><author-notes><fn fn-type="corresp" id="C1"><label>1</label><p>Correspondence: Endocrinology Unit, Centre for Cardiovascular Sciences, The Queen&#x02019;s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. E-mail: <email>karen.chapman&#x00040;ed.ac.uk</email></p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>11</month><year>2008</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the //ART/@DATE. --><volume>22</volume><issue>11</issue><fpage>3896</fpage><lpage>3907</lpage><history><date date-type="received"><day>21</day><month>4</month><year>2008</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2009 The Author(s)</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/us/">http://creativecommons.org/licenses/by-nc/3.0/us/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><self-uri xlink:title="pdf" xlink:href="z3801108003896.pdf"/><abstract><p>Glucocorticoid hormones are critical to respond and adapt to stress. Genetic variations in the glucocorticoid receptor (GR) gene alter hypothalamic-pituitary-adrenal (HPA) axis activity and associate with hypertension and susceptibility to metabolic disease. Here we test the hypothesis that reduced GR density alters blood pressure and glucose and lipid homeostasis and limits adaption to obesogenic diet. Heterozygous <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice were generated from embryonic stem (ES) cells with a gene trap integration of a &#x003b2;-galactosidase-neomycin phosphotransferase (&#x003b2;geo) cassette into the <italic>GR</italic> gene creating a transcriptionally inactive GR fusion protein. Although <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have 50% less functional GR, they have normal lipid and glucose homeostasis due to compensatory HPA axis activation but are hypertensive due to activation of the renin-angiotensin-aldosterone system (RAAS). When challenged with a high-fat diet, weight gain, adiposity, and glucose intolerance were similarly increased in control and <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, suggesting preserved control of intermediary metabolism and energy balance. However, whereas a high-fat diet caused HPA activation and increased blood pressure in control mice, these adaptions were attenuated or abolished in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. Thus, reduced GR density balanced by HPA activation leaves glucocorticoid functions unaffected but mineralocorticoid functions increased, causing hypertension. Importantly, reduced GR limits HPA and blood pressure adaptions to obesogenic diet.&#x02014;Michailidou, Z., Carter, R. N., Marshall, E., Sutherland, H. G., Brownstein, D. G., Owen, E., Cockett, K., Kelly, V., Ramage, L., Al-Dujaili, E. A. S., Ross, M., Maraki, I., Newton, K., Holmes, M. C., Seckl, J. R., Morton, N. M., Kenyon, C. J., Chapman, K. E. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.</p></abstract><kwd-group><kwd>HPA axis</kwd><kwd>diet-induced obesity</kwd><kwd>NR3C1</kwd><kwd>glucose and lipid homeostasis</kwd></kwd-group></article-meta></front><body><p><sc>Glucocorticoids coordinately regulate</sc> gene pathways in response to external (stress) and internal (circadian) cues and form part of important homeostatic control mechanisms, critical in adaption to environmental stressors. They are required for the integrity of central nervous system function, for the response to infection and injury, and for cardiovascular and metabolic homeostasis. They regulate blood pressure <xref rid="B1" ref-type="bibr">(1)</xref>, energy intake and expenditure, and glucose and lipid homeostasis <xref rid="B2" ref-type="bibr">(2)</xref>. In excess, glucocorticoids cause hypertension, visceral obesity, insulin resistance/diabetes, and disordered mood and cognition (Cushing&#x02019;s syndrome), whereas glucocorticoid deficiency causes hypotension, fatigue, weight loss, and anorexia.</p><p>Most actions of glucocorticoids are mediated through the widely distributed glucocorticoid receptor (GR; refs. <xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr">5</xref>), which belongs to the superfamily of nuclear receptor transcription factors <xref rid="B6" ref-type="bibr">(6)</xref>. Studies <italic>in vitro</italic><xref rid="B7" ref-type="bibr">(7</xref><xref rid="B8" ref-type="bibr">, 8)</xref> and <italic>in vivo</italic><xref rid="B9" ref-type="bibr">(9</xref><xref rid="B10" ref-type="bibr">, 10)</xref> have shown the importance of receptor density in determining cellular glucocorticoid sensitivity. Complete loss of GR is incompatible with postnatal survival <xref rid="B11" ref-type="bibr">(11</xref><xref rid="B12" ref-type="bibr">, 12)</xref>, but partial loss of GR function in humans causes the rare familial/sporadic glucocorticoid resistance syndrome <xref rid="B13" ref-type="bibr">(13)</xref>, characterized by hypercortisolism without other features of Cushing&#x02019;s syndrome. Polymorphisms in the human <italic>Nr3c1</italic> gene (encoding GR; here abbreviated to <italic>GR</italic>) are associated with hyper- or hyposensitivity to exogenous glucocorticoid (dexamethasone) suppression of the hypothalamic-pituitary-adrenal (HPA) axis and a range of metabolic and cardiovascular parameters. Thus, polymorphisms associated with glucocorticoid hypersensitivity (<italic>Bcl</italic>I, N363S) are typically (dependent on age, gender, and ethnic background) associated with hypertension, obesity, decreased lean mass, insulin resistance, and increased risk of cardiovascular disease despite reduced plasma cortisol levels, whereas the ER22/23EK polymorphism, associated with glucocorticoid hyposensitivity, is associated with beneficial metabolic outcomes (reviewed in ref. <xref rid="B14" ref-type="bibr">14</xref>).</p><p>Several mouse lines with altered GR expression or function have been generated to investigate the role of GR in HPA axis regulation and its role in mood regulation and in the immune system (reviewed in refs. <xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref><xref rid="B17" ref-type="bibr">17</xref>). Fewer studies have investigated the effects of altered GR density on cardiovascular and metabolic outcomes. Reduced GR density through antisense GR transgene expression (central nervous system targeted, although widely expressed) lowered energy intake but also caused obesity <xref rid="B18" ref-type="bibr">(18</xref><xref rid="B19" ref-type="bibr">, 19)</xref>. However, neuron-specific deletion of <italic>GR</italic> caused a small-lean phenotype postweaning and increased energy expenditure, due to the peripheral effects of high glucocorticoid levels coupled with normal levels of peripheral GR <xref rid="B20" ref-type="bibr">(20)</xref>. Liver-specific <italic>GR</italic> gene deletion led to hypoglycemia, but only after prolonged starvation, and ameliorated hyperglycemia in streptozotocin-induced diabetes <xref rid="B21" ref-type="bibr">(21)</xref>. Recently, transgenic mice have been described with cardiomyocyte-specific GR overexpression. These mice display conduction defects, reduced heart rate, atrioventricular block, altered calcium homeostasis, and ion channel remodeling in isolated cardiomyocytes <xref rid="B22" ref-type="bibr">(22)</xref>. Although these studies have provided important information on the tissue-specific functions of GR, the cardiovascular and metabolic consequences of globally altered GR density, and hence glucocorticoid sensitivity, have not been described, although this is the clinically relevant situation.</p><p>Here we have generated a novel line of mice with reduced GR density, heterozygous for a null mutation of the <italic>GR</italic> gene (<italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup>), to investigate whether global reduction in GR density alters cardiovascular (blood pressure), fat distribution, and metabolic (glucose and lipid homeostasis) parameters. A high-fat (HF) diet was introduced to determine whether <italic>GR</italic> haploinsufficiency altered the adaptive hormonal and metabolic changes that accompany dietary-induced obesity.</p><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Generation of <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice</title><p>A mouse ES cell line (ESKN92) generated by gene-trap mutagenesis in which a &#x003b2;-galactosidase-neomycin phosphotransferase (&#x003b2;geo) reporter cassette integrated within the <italic>GR</italic> gene, generating a translational fusion between GR and &#x003b2;geo, has been described previously <xref rid="B23" ref-type="bibr">(23)</xref>. 5&#x02032;-Rapid amplification of cDNA ends (RACE) confirmed integration of the &#x003b2;-galactosidase-neomycin phosphotransferase (&#x003b2;geo) reporter cassette between exons 3 and 4 of the <italic>GR</italic> gene. Fluorescence <italic>in situ</italic> hybridization (FISH) confirmed a single integration site on chromosome 18 at the <italic>GR</italic> locus. Chimeric mice were generated by injection of ESKN92 cells into C57BL/6J blastocysts. Chimeras were mated to C57BL/6J female mice to achieve germ line transmission and further backcrossed to generate a congenic line (full name, <italic>Nr3c1</italic><sup><italic>gtESK92MRCHGU</italic></sup>; here abbreviated to <italic>GR</italic><sup>&#x003b2;<italic>geo</italic></sup>). Heterozygotes were identified by polymerase chain reaction (PCR) for the presence of <italic>lacZ</italic> (in the &#x003b2;geo cassette) using the following primers: forward, 5&#x02032;-GTTGCGCAGCCTGAATGGCG-3&#x02032;; and reverse, 5&#x02032;-GCCGTCACTCCAACGCAGCA-3&#x02032;. All the experiments described were performed on adult male (5&#x02013;6 months) <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> and <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates, backcrossed for five generations (F<sub>5</sub>) to C57BL/6J. Experimental groups were 8 to 9 per group, unless otherwise stated. To generate homozygous <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x003b2;<italic>geo</italic></sup> mice, F<sub>7</sub><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice were intercrossed.</p></sec><sec><title>Animal maintenance and diets</title><p>All animal experimentation was conducted in strict accord with the accepted standards of humane animal care under the auspices of the Animal (Scientific Procedures) Act UK 1986 after prior approval by the local ethical committee. Mice were housed in standard cages under controlled lighting (12:12-h light-dark cycle, lights on at 7 AM) and were fed standard chow from weaning unless specified otherwise. For measurement of unstressed plasma corticosterone ACTH and glucose in tail nick blood samples, animals were acclimatized to single housing and tail nicks were performed within 1 min of disturbing the cage. For diet-induced obesity experiments, mice were weaned onto either HF/low carbohydrate diet (58% kcal as fat, D12331; Research Diets, New Brunswick, NJ, USA) or low-fat (LF)/high-carbohydrate diet (11% kcal as fat, D12328; Research Diets) and remained on the diet for 22 wk with <italic>ad libitum</italic> access to water and diet. Body weight and food intake were monitored weekly and for 3 wk, respectively.</p></sec><sec><title>Tissue collection, metabolic parameters, and liver triglyceride levels</title><p>Experimental mice were killed by decapitation between 8 and 10 AM. Trunk blood samples were collected into EDTA-coated tubes (Sarstedt, N&#x000fc;mbrecht, Germany) and centrifuged (6000 <italic>g</italic>, 10 min), and plasma was stored at &#x02212;80&#x000b0;C before assay. Tissues were rapidly frozen in dry ice for RNA or Western blot analysis or fixed in formalin (left adrenal, kidney) for histology. Evening plasma corticosterone levels were determined from blood sampled (by tail nick) at 7 PM. Plasma corticosterone was measured by an in-house radioimmunoassay as described previously <xref rid="B24" ref-type="bibr">(24)</xref>. Plasma ACTH levels were measured by ELISA (Biomerica, Newport Beach, CA, USA). For the glucose tolerance test (GTT), animals were deprived of food for 6 h, 2 mg/g body weight of 25% glucose was injected intraperitoneally, and tail nick blood sampling was performed at time 0 (before injection) and 15, 30, 60, and 120 min after injection. Plasma glucose was measured using a glucose monitoring system (One Touch Ultra, Lifescan, Johnson &#x00026; Johnson, Langhorne, PA, USA), insulin by ELISA (Crystalchem, Downers Grove, IL, USA), nonesterified fatty acids (NEFAs) with a NEFA C kit (Wako Chemicals GmbH, Nuess, Germany), and triglycerides with an L-type triglyceride kit (Wako Chemicals GmbH). Insulin, NEFAs, and triglycerides were measured after 24 h of food deprivation. Hepatic triglycerides were extracted after homogenization of 100 mg liver in isopropanol (10 vol) and then incubation at 37&#x000b0;C for 45 min. After centrifugation (3000 <italic>g</italic>, 10 min), 10 &#x003bc;l supernatant was incubated at 37&#x000b0;C for 5 min with 1 ml Thermotrace triglyceride reagent (Alpha Laboratories, Eastleigh, UK) and absorbance at 500 nm was measured. Plasma renin activity and angiotensinogen concentration were measured by radioimmunoassay as described previously <xref rid="B25" ref-type="bibr">(25)</xref>. Plasma aldosterone concentration was measured by in-house ELISA as described previously <xref rid="B26" ref-type="bibr">(26</xref><xref rid="B27" ref-type="bibr">, 27)</xref>. Formalin-fixed tissues were processed for histopathology, sectioned (4 &#x003bc;m), and stained with hematoxylin and eosin for histopathological examination.</p></sec><sec><title>Blood pressure measurements</title><p>Systolic blood pressure was measured on 2 separate days in conscious mice by tail cuff plethysmography (Harvard Apparatus, Edenbridge, UK) as described previously <xref rid="B28" ref-type="bibr">(28)</xref>. Before measurements were recorded, all mice underwent three periods of training to acclimatize them to the procedure. Mice were kept at 37&#x000b0;C for 10 min before measurements were initiated. Mean systolic blood pressure was calculated from the mean of 12 measurements per mouse.</p></sec><sec><title>RNA extraction and real-time PCR</title><p>Total RNA was extracted from frozen tissues as described previously <xref rid="B25" ref-type="bibr">(25)</xref>. One microgram of RNA was pretreated with DNaseI (Invitrogen, Paisley, UK) and then reverse transcribed into cDNA using oligo(dT) primer and Superscript III first strand cDNA synthesis kit (Invitrogen). Real-time PCR was carried out on cDNA using a LightCycler 480 (Roche Diagnostics, Burgess Hill, UK) with a commercial master mix (FAM-hydrolysis probe, Roche Diagnostics) and the following primer/probe sets (Applied Biosystems, Foster City, CA, USA): &#x003b2;-actin, Mm00607939_s1; GR, Mm01260497_m1 (amplicon spanning exons 5&#x02013;6) and Mm00433832_m1 (amplicon spanning exons 2&#x02013;3); 11&#x003b2;-HSD1, Mm00476182_m1; angiotensinogen, Mm00599662; 11&#x003b2;-HSD2, Mm00492541_g1; and mineralocorticoid receptor (MR), Mm01241597_m1. Renin primers were in-house primers as follows: forward, 5&#x02032;-GGTGCCCTCCACCAAGTG-3&#x02032;; reverse 5&#x02032;-TCAGAGGACTCATAGAGGCTGTGA-3&#x02032;; and probe, 5&#x02032;-AGCCGCCTCTACCTTGCTTGTGGG-3&#x02032;. Negative controls omitting Superscript III or RNA were included. Annealing temperature was 60&#x000b0;C. Data were analyzed using the second derivative maximum method. The ratio of levels of the transcript of interest to levels of &#x003b2;-actin mRNA was determined for each sample.</p></sec><sec><title><italic>In situ</italic> mRNA hybridization</title><p>Brain and pituitary GR mRNA levels were determined by <italic>in situ</italic> mRNA hybridization histochemistry, as described previously <xref rid="B29" ref-type="bibr">(29)</xref>. Briefly, coronal brain sections (10 &#x003bc;m) were hybridized overnight at 55&#x000b0;C to <sup>35</sup>S-labeled GR cRNA probe complementary to exons 5&#x02013;9 of <italic>GR</italic> (<xref rid="B29" ref-type="bibr">29</xref>; absent from ESKN92-encoded GR-&#x003b2;geo mRNA). Sections were then treated with RNase at 37&#x000b0;C for 1 h and washed at 60&#x02013;70&#x000b0;C. Hybridized sections were exposed to autoradiographic film for 7 days. For densitometry, autoradiographs were imaged on a lightbox fitted with a coolsnap photometrics camera and analyzed using MCID software (InterFocus Imaging, Cambridge, UK).</p></sec><sec><title>Western blotting</title><p>Fifty milligrams of epididymal fat tissue was homogenized in 600 &#x003bc;l protein extraction buffer (Invitrogen). Proteins (25 &#x003bc;g homogenate) were resolved on 4&#x02013;12% Bris-Tris Novex precast Gels (Invitrogen), transferred to a nitrocellulose membrane, and then incubated with a GR-specific antibody (M-20, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunoreactive bands were visualized by chemiluminesense (ECL kit; Amersham Biosciences, Little Chalfont, UK). An anti-&#x003b2;-tubulin monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA) or membrane staining with Ponceau red were used to verify equal protein loading between samples.</p></sec><sec><title>X-gal staining</title><p>X-gal (5-bromo-4-chloro-3-indolyl-&#x003b2;-<sc>d</sc>-galactopyranoside) staining to detect &#x003b2;-galactosidase activity was carried out on frozen coronal brain sections (10 &#x003bc;m). Sections were transferred directly from &#x02212;80&#x000b0;C into fixative (4% paraformaldehyde, 0.02% Nonidet P-40, 0.01% sodium deoxycholate, 5 mM EGTA, and 2 mM MgCl<sub>2</sub>) for 15 min at 4&#x000b0;C; washed twice in PBS containing 2 mM MgCl<sub>2</sub>, 0.02% Nonidet P-40, and 0.01% sodium deoxycholate; and stained for 6 h in PBS containing 2 mM MgCl<sub>2</sub>, 0.02% Nonidet P-40, 0.01% sodium deoxycholate, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal.</p></sec><sec><title>Transfection assays</title><p>Human embryonic kidney (HEK293) cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 &#x003bc;g/ml streptomycin, at 37&#x000b0;C, 5% CO<sub>2</sub>. For transfection, 2.5 &#x000d7; 10<sup>5</sup> cells were seeded per well in 6-well plates coated with poly-<sc>d</sc>-lysine in DMEM supplemented with 10% charcoal-stripped fetal calf serum and transfected the following day using Lipofectamine 2000 (Invitrogen) with 500 ng reporter plasmid, 200 ng expression plasmid and/or empty vector, pcDNA3.1(&#x02212;) (Invitrogen), and 50 ng pRL-CMV (Promega, Southampton, UK) encoding renilla luciferase, used as internal control. Dexamethasone (1 &#x003bc;M) was added 1 h after transfection, and the cells were harvested 48 h later for luciferase assays. Reporter plasmids were MMTV-LTR-luciferase <xref rid="B30" ref-type="bibr">(30)</xref> or rPNMT-998/-466 Luc <xref rid="B31" ref-type="bibr">(31)</xref>. Expression plasmids encoded wild-type (WT) mouse GR or GR-&#x003b2;geo. WT GR was subcloned from pSV2wrec <xref rid="B32" ref-type="bibr">(32)</xref>. A polymorphism within the DNA binding domain of the pSV2wrec-encoded GR (encoding Val437) <xref rid="B33" ref-type="bibr">(33)</xref> was changed to Gly437, to be identical to the C57BL/6J and 129 mouse strain-encoded GR, by site-directed mutagenesis. The GR-&#x003b2;geo cDNA was assembled from the WT GR cDNA, the 5&#x02032;-RACE product, and the pGT3 vector in the gene trap <xref rid="B23" ref-type="bibr">(23)</xref> by subcloning of appropriate DNA fragments. All constructs were verified by DNA sequencing.</p></sec><sec><title>Statistical analysis</title><p>The effects of genotype and diet were assessed by two-way ANOVA followed by <italic>post hoc</italic> Tukey&#x02019;s tests for group differences. Significance was set at <italic>P</italic> &#x0003c; 0.05. To evaluate significant differences in GR mRNA levels between <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> and <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, a Student&#x02019;s <italic>t</italic> test was used. For GTT comparisons, the area under the curve was calculated for each animal and then group means compared with 2-way ANOVA. For transfection assays, data were analyzed by ANOVA, followed by <italic>post hoc</italic> tests. Values are means &#x000b1; <sc>se</sc>.</p></sec></sec><sec><title>RESULTS</title><sec><title><italic>GR</italic>-&#x003b2;<italic>geo</italic> allele is a null allele that decreases functional GR levels in heterozygous mice</title><sec><title>Generation of GR<sup>&#x003b2;geo/&#x0002b;</sup> mice</title><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mutant mice were generated from an ES cell line (ESKN92) in which a &#x003b2;geo reporter cassette had integrated into the <italic>GR</italic> gene, generating a transcriptional and translational fusion <xref rid="B23" ref-type="bibr">(23)</xref>. 5&#x02032;-RACE carried out on ESKN92 RNA and PCR analysis of genomic DNA demonstrated the site of integration between exons 3 and 4 (data not shown). The resulting fusion protein lacks part of the DNA binding domain and the entire ligand binding domain (<xref rid="F1" ref-type="fig"><bold>Fig. 1</bold>A</xref>).</p></sec><sec><title>The encoded protein is transcriptionally inactive</title><p>The ability of the GR-&#x003b2;geo fusion protein to activate transcription was tested in transfected HEK293 cells, which lack functional endogenous GR. In contrast to WT GR, the GR-&#x003b2;geo fusion protein had no effect on promoter activity either in the presence or absence of dexamethasone (<xref rid="F1" ref-type="fig">Fig. 1<italic>B</italic>, <italic>C</italic></xref>), demonstrating that it is transcriptionally inactive and that the exon 2&#x02013;3 encoded portion of GR, present in the fusion protein, has no constitutive activity. Importantly, cotransfection of GR-&#x003b2;geo with WT GR had no effect on dexamethasone-mediated WT GR transactivation of either MMTV-LTR (<xref rid="F1" ref-type="fig">Fig. 1<italic>B</italic></xref>) or the PNMT promoter (<xref rid="F1" ref-type="fig">Fig. 1<italic>C</italic></xref>), demonstrating that the fusion protein does not exert a dominant-negative activity. Thus, although the fusion protein is expressed in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<italic>e.g</italic>., <xref rid="F2" ref-type="fig"><bold>Fig. 2</bold></xref>), these properties predict that the <italic>GR-&#x003b2;geo</italic> allele is a null allele.</p></sec><sec><title>Homozygous GR<sup>&#x003b2;geo/&#x003b2;geo</sup> mice die postnatally</title><p>Previous data have shown that homozygosity for a null allele of <italic>GR</italic> is lethal <xref rid="B34" ref-type="bibr">(34)</xref>, whereas &#x0223c;10&#x02013;15% of mice homozygous for a hypomorphic allele survive <xref rid="B11" ref-type="bibr">(11)</xref>. To test the lethality of the <italic>GR-&#x003b2;geo</italic> allele, heterozygous <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice were intercrossed. Of 145 offspring, none were homozygous for the <italic>GR-&#x003b2;geo</italic> allele, suggesting that homozygous mice die before adulthood, consistent with previous data showing the lethality of a null allele around birth <xref rid="B11" ref-type="bibr">(11</xref><xref rid="B34" ref-type="bibr">, 34)</xref>. In contrast, examination of embryos from heterozygous intercrosses showed the presence of homozygous <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x003b2;<italic>geo</italic></sup> embryos at the expected frequency (26.6%).</p></sec><sec><title>Functional GR levels are reduced in <italic>GR</italic><sup>&#x003b2;geo/&#x0002b;</sup> mice</title><p>X-gal staining of brain sections from <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice showed expression of GR-&#x003b2;geo throughout the brain, mirroring normal GR mRNA expression (<xref rid="F2" ref-type="fig">Fig. 2<italic>A</italic>, <italic>B</italic></xref>). Moreover, quantitative PCR (qPCR) measurements of GR mRNA levels in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> and <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice using primers that span exons 2&#x02013;3 (present in both normal <italic>GR</italic> and <italic>GR-&#x003b2;geo</italic> alleles) did not differ between genotypes (data not shown). However, <italic>in situ</italic> mRNA hybridization histochemistry of GR mRNA, using a probe complementary to exons 5&#x02013;9 of <italic>GR</italic> (absent from mRNA encoding GR-&#x003b2;geo; <xref rid="F1" ref-type="fig">Fig. 1<italic>A</italic></xref>) showed a halving in the full-length GR mRNA levels in the brain (hippocampus and paraventricular nucleus of the hypothalamus) and pituitary of <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice compared with <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates (<xref rid="F2" ref-type="fig">Fig. 2<italic>B</italic>&#x02013;<italic>D</italic></xref>; <xref rid="T1" ref-type="table">Table 1</xref>). Similarly, qPCR to detect exons 5&#x02013;6 showed that <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice had &#x0223c;50% reduced full-length GR mRNA levels in adipose tissue, muscle, liver, and adrenal gland <xref rid="T1" ref-type="table">(Table 1)</xref>. Interestingly, the decrease measured in the adrenal gland was significantly greater than that in adipose tissue and liver (<italic>P</italic>&#x0003c;0.05; repeated one-way ANOVA), possibly reflecting developmental effects. Western blot analysis showed similar reductions in a 95 kDa GR protein in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<xref rid="F3" ref-type="fig"><bold>Fig. 3</bold></xref>). A 191 kDa immunoreactive protein, corresponding to the predicted mass of the GR-&#x003b2;geo fusion protein, was detected in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> but not in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mouse tissues <xref rid="F3" ref-type="fig">(Fig. 3)</xref>.</p></sec></sec><sec><title><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice show altered HPA adaption to HF diet</title><sec><title>Differing HPA axis alterations in response to HF diet in GR<sup>&#x003b2;geo/&#x0002b;</sup> mice</title><p>HF diets stimulate the HPA axis <xref rid="B35" ref-type="bibr">(35)</xref> and induce hypertension <xref rid="B36" ref-type="bibr">(36</xref><xref rid="B37" ref-type="bibr">, 37)</xref>. It is well known that GR manipulations affect the HPA axis <xref rid="B15" ref-type="bibr">(15)</xref>. To establish that HPA axis activity is increased in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice and to determine whether reduced GR levels alter the metabolic adaption to an HF diet, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice were weaned onto a defined HF or LF diet and maintained on the diets for 22 wk. Although on the LF diet <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice had elevated plasma corticosterone levels (basal and peak) compared with <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (<xref rid="F4" ref-type="fig"><bold>Fig. 4</bold></xref>), consistent with the predicted increase in basal HPA axis activity in GR deficiency <xref rid="B15" ref-type="bibr">(15)</xref>, they resisted the HF diet-induced increase in basal (morning) plasma corticosterone levels <xref rid="F4" ref-type="fig">(Fig. 4)</xref>. Thus, while the HF diet increased basal corticosterone levels in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice by &#x0223c;2-fold, it had no significant effect on basal corticosterone levels in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, resulting in no difference between mice of the two genotypes fed the HF diet <xref rid="F4" ref-type="fig">(Fig. 4)</xref>. Peak circulating corticosterone levels remained higher in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice compared with their <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates and were unaffected by diet (<xref rid="F4" ref-type="fig">Fig. 4<italic>B</italic></xref>). There was no significant difference between genotypes in basal (morning) plasma ACTH levels in either LF-fed (data not shown) or HF-fed mice (<italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup><italic>vs</italic>. <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup>: 38&#x000b1;8 and 19&#x000b1;7 pg/ml, respectively), consistent with the similar basal plasma corticosterone levels in the latter. Similarly, there were no significant effects of either genotype or diet on pituitary POMC mRNA levels, although there was a trend for the HF diet to increase POMC mRNA levels, only in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (LF- <italic>vs</italic>. HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice: 0.7&#x000b1;0.1 and 1.3&#x000b1;0.3, <italic>n</italic>&#x0003d;2 and 5, respectively, <italic>P</italic>&#x0003d;0.3; LF- <italic>vs</italic>. HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice: 0.9&#x000b1;0.2 and 0.9&#x000b1;0.2, respectively, <italic>n</italic>&#x0003d;5/group). Strikingly, and similar to basal plasma corticosterone levels, adrenal weight was significantly higher in LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice compared with their <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates, but, in contrast to <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice, in which adrenal weight was increased by the HF diet, the HF diet had no effect on adrenal weight in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<xref rid="F4" ref-type="fig">Fig. 4<italic>C</italic></xref>). Adrenal morphology also differed between genotypes, and this was particularly apparent on the LF diet (<xref rid="F5" ref-type="fig"><bold>Fig. 5</bold></xref>). The morphology suggests stimulation of corticosterone- and aldosterone-producing cells of <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice in the zona fasciculata and glomerulosa, respectively. In adrenal glands from <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, the columns of endocrine cells in the zona fasciculata are longer than in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice, with individual cells having homogeneous eosinophilic cytoplasm (<xref rid="F5" ref-type="fig">Fig. 5<italic>A</italic>&#x02013;<italic>D</italic></xref>). The zona glomerulosa of <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> adrenal glands appears thicker than in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice, with more glomeruli evident and containing hypertrophied epithelium (<xref rid="F5" ref-type="fig">Fig. 5<italic>C</italic>, <italic>D</italic></xref>). This adrenal phenotype was also apparent in mice fed the HF diet (<xref rid="F5" ref-type="fig">Fig. 5<italic>E</italic>, <italic>F</italic></xref>), but the morphological differences between LF and HF groups were more pronounced in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice than in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice <xref rid="F5" ref-type="fig">(Fig. 5)</xref>. Measurements of adrenal cell size in the different zones (glomerulosa, fascilulata, and reticularis) did not differ between genotypes (data not shown), indicating that the larger adrenal glands in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice reflect hyperplasia rather than cellular hypertrophy.</p></sec><sec><title>GR<sup>&#x003b2;geo/&#x0002b;</sup> mice have normal adipose tissue distribution and glucose homeostasis but higher liver triglyceride levels on HF diet</title><p>Although <italic>GR</italic> polymorphisms in humans are associated with alterations in body weight and/or composition (reviewed in ref. <xref rid="B14" ref-type="bibr">14</xref>), there were no differences in body weight (<xref rid="F6" ref-type="fig"><bold>Fig. 6</bold>A</xref>) or food intake (data not shown) between <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice and their <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates, on either the LF or HF diet. There were also no differences between genotypes on either diet in weights of adipose tissue (epididymal, inguinal, and mesenteric) and muscle (extensor digitorum longus) or in plasma levels of insulin, NEFAs, and triglyceride (<xref rid="T2" ref-type="table">Table 2</xref>). However, while the HF diet caused the expected increase in liver triglyceride levels in both genotypes, levels were higher in HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> than in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice <xref rid="T2" ref-type="table">(Table 2)</xref>. Both genotypes fed the LF diet showed similar responses in GTTs with an identical impaired response in mice fed HF diet (<xref rid="F6" ref-type="fig">Fig. 6<italic>B</italic></xref>).</p></sec></sec><sec><title><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice are hypertensive and show an attenuated blood pressure response to HF diet</title><p>In LF-fed mice, systolic blood pressure was significantly elevated (8 mmHg) in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice compared with their <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> littermates (<xref rid="F7" ref-type="fig"><bold>Fig. 7</bold></xref>). Furthermore, blood pressure was increased in both genotypes by the HF diet, although interestingly the magnitude of the increase was lower in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (8 mmHg) than in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (14 mmHg), resulting in no difference in blood pressure between genotypes in mice fed the HF diet <xref rid="F7" ref-type="fig">(Fig. 7)</xref>.</p></sec><sec><title><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have an activated RAAS</title><p>Increased systolic blood pressure in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice was associated with a 2-fold increase in plasma renin activity, which was unaffected by diet in either genotype, remaining higher in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<xref rid="F8" ref-type="fig"><bold>Fig. 8</bold>A</xref>). Similarly, plasma aldosterone levels were increased in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, irrespective of diet (<xref rid="F8" ref-type="fig">Fig. 8<italic>B</italic></xref>). Plasma angiotensinogen levels were comparable between LF diet-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> and <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice but were markedly increased (3-fold) by the HF diet only in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<xref rid="F8" ref-type="fig">Fig. 8<italic>C</italic></xref>). Hepatic angiotensinogen mRNA levels mirrored the pattern of plasma angiotensinogen (<xref rid="F8" ref-type="fig">Fig. 8<italic>E</italic></xref>). Increased adipose tissue expression of angiotensinogen, although much lower than hepatic expression, has been postulated to contribute to or even underlie hypertension in diet-induced obesity <xref rid="B38" ref-type="bibr">(38)</xref>. However, although we observed higher expression of angiotensinogen mRNA in epididymal adipose tissue of LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice compared with <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice, levels were lower in HF-fed mice and did not differ between genotypes (<xref rid="F8" ref-type="fig">Fig. 8<italic>E</italic></xref>). Neither kidney nor adrenal renin mRNA levels differed between genotypes on the LF diet nor were they altered by the HF diet (<xref rid="T3" ref-type="table">Table 3</xref>). Similarly, renal 11&#x003b2;-HSD2 and MR mRNA levels, both critical determinants of blood pressure <xref rid="B39" ref-type="bibr">(39)</xref>, were identical between genotypes and they did not differ with diet <xref rid="T3" ref-type="table">(Table 3)</xref>. Thus, activation of the RAAS in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice is likely to underlie their hypertension but does not account for changes in blood pressure after the HF diet. The activation of RAAS in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice was not accompanied by grossly abnormal kidney function, since kidney morphology was similar in both genotypes (data not shown).</p></sec></sec><sec><title>DISCUSSION</title><p>Although <italic>GR</italic> polymorphisms are associated with hypertension and differences in body mass index and body composition in humans, few animal studies have addressed the effects of altered GR density on body weight and composition and none have examined the effect on metabolic adaption to the HF diet. Here we found that reduced tissue GR density has no effect on body weight, adipose tissue distribution or glucose homeostasis, basally, on a chow diet (unpublished observations) or an LF diet or after an HF diet. However, like most humans heterozygous for mutations in the <italic>GR</italic> gene, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have an activated HPA axis and, as we have now shown, elevated blood pressure. Interestingly, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice failed to show the full extent of the HPA and blood pressure adaptions to the HF diet seen in control mice, suggesting that tissue GR density limits the adaptive response to chronic dietary stress.</p><p>As expected, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice display a hyperactive HPA axis, with elevated plasma corticosterone and larger adrenal glands. The latter results from hyperplasia rather than cellular hypertrophy, since adrenal cell size was not different in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice in any of the zones. This is consistent with previous data showing increased plasma corticosterone levels in mice with reduced GR density <xref rid="B11" ref-type="bibr">(11</xref><xref rid="B18" ref-type="bibr">, 18)</xref>, although measurements in these previous studies are likely to have been stress levels. It differs, however, from a previous study in mice heterozygous for a null allele of <italic>GR</italic> (<italic>GR</italic><sup><italic>null</italic>/&#x0002b;</sup>) in which nonstressed plasma corticosterone levels, both morning and evening, were the same as in control mice, although the mice did show an increased plasma corticosterone response to stress <xref rid="B40" ref-type="bibr">(40)</xref>, similar to <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (our unpublished data). The discrepancy in nonstressed plasma corticosterone levels between the two models may be related to environmental or strain differences: here, backcrossed to C57BL/6J for five generations, whereas Ridder <italic>et al</italic>. <xref rid="B40" ref-type="bibr">(40)</xref> examined F<sub>1</sub> offspring of a C57BL/6J X FVB/N cross. We <xref rid="B41" ref-type="bibr">(41)</xref> have noted higher basal plasma corticosterone levels in FVB/N mice.</p><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have completely normal body weight, regional adiposity, and lean mass. Glucose homeostasis (measured by fasting plasma glucose) and insulin levels, as well as glucose tolerance, were also entirely normal in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. This metabolic phenotype contrasts with the obesity seen in chow-fed transgenic mice with globally reduced GR density because of antisense GR RNA expression <xref rid="B18" ref-type="bibr">(18</xref><xref rid="B19" ref-type="bibr">, 19)</xref>. These mice, similar to <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, also show an activated HPA axis <xref rid="B18" ref-type="bibr">(18)</xref>. The reason for the discrepancy between these two models, each with reduced GR and elevated corticosterone, is not clear but may relate to the unknown effects of the <italic>GR</italic> transgene in the antisense GR-expressing mice in which knockdown of the GR is achieved through use of a neurofilament gene promoter, which may be differentially expressed within the central nervous system. Mice with a conditional deletion of the <italic>GR</italic> gene in neurons have very high plasma corticosterone levels due to a lack of negative feedback at the hypothalamus <xref rid="B42" ref-type="bibr">(42)</xref>. However, these mice have normal peripheral GR levels, are growth retarded, and have proportionately more body fat before weaning, but less after <xref rid="B20" ref-type="bibr">(20)</xref>. In <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, reduced peripheral GR density may compensate for the increased plasma corticosterone levels, normalizing body fat distribution. The lack of effect of genotype on glucose homeostasis is not surprising, as selective <italic>GR</italic> gene deletion in hepatocytes showed that GR is essential for glucose homeostasis only after prolonged fasting or in a diabetic state <xref rid="B21" ref-type="bibr">(21)</xref>. Moreover, antisense GR mice also show normal glucose homeostasis <xref rid="B19" ref-type="bibr">(19)</xref>.</p><p>Like most humans heterozygous for inactivating mutations in the <italic>GR</italic> gene <xref rid="B43" ref-type="bibr">(43)</xref>, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice are hypertensive. In <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, the hypertension results from elevated activity of the renin-angiotensin-aldosterone system. Plasma aldosterone levels were increased in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, as was plasma renin activity. The latter, however, was not associated with increased expression of renin mRNA in either the kidney or adrenal gland. A similar discrepancy between plasma renin and mRNA levels has previously been reported and postulated to be due to the more rapid secretion and turnover of newly synthesized renin compared with the long half-life of renin mRNA <xref rid="B44" ref-type="bibr">(44)</xref>. Alternatively, renin clearance may be increased in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. Despite reduced GR density and elevated plasma corticosteroid levels in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, there were no compensatory changes, at least in the kidney, in the expression of MR or 11&#x003b2;-HSD2, which protects MR from illicit occupation by glucocorticoids <xref rid="B39" ref-type="bibr">(39)</xref>. Similarly, MR levels in the brain are normal in mice with forebrain-specific deletion of <italic>GR</italic><xref rid="B45" ref-type="bibr">(45)</xref>, suggesting that MR density is not altered to compensate for reduced GR expression. The increased plasma aldosterone levels in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice were consistent with the adrenal histopathology, suggesting high synthetic activity of aldosterone producing cells. This was predicted from the phenotype of <italic>GR</italic><sup><italic>hypo/hypo</italic></sup> mice, which have elevated levels of aldosterone synthase in the zona glomerulosa <xref rid="B11" ref-type="bibr">(11)</xref>, and is probably a consequence of elevated plasma ACTH levels in these mice. Indeed, <italic>Pomc</italic><sup>&#x02212;/&#x02212;</sup> mice, which lack circulating ACTH, have small adrenal glands and dramatically reduced plasma aldosterone levels <xref rid="B46" ref-type="bibr">(46)</xref>.</p><p>HF diets chronically stress the HPA axis in rodents, increasing basal corticosterone levels and causing adrenal enlargement <xref rid="B35" ref-type="bibr">(35</xref><xref rid="B47" ref-type="bibr">, 47)</xref>, although negative feedback efficiency is unaffected by HF diet <xref rid="B35" ref-type="bibr">(35)</xref>. Consistent with this, in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice, the HF diet from weaning increased adrenal size and increased morning plasma corticosterone levels. In contrast, in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, the HF diet had no effect on either of these parameters. Thus, differences between genotypes in these parameters were eliminated by the diet. Evening (nonstressed) plasma corticosterone levels were unaffected by the HF diet and remained higher in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. These results suggest that the HPA axis response to the HF diet is limited by tissue GR density, this adaptive response being abolished by a 50% reduction in GR levels.</p><p>Surprisingly, given the role of glucocorticoids in energy homeostasis <xref rid="B2" ref-type="bibr">(2)</xref>, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice showed an entirely normal body weight gain, altered glucose homeostasis and insulin sensitivity on the HF diet, and did not differ from <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> controls. Similarly, mice of both genotypes fed the HF diet doubled their hepatic accumulation of triglyceride compared with mice on the control diet, although hepatic triglyceride levels were significantly higher in HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice than in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice. Although plasma NEFAs did not differ between LF- and HF-fed mice, these were measured after a 24 h fast, when NEFAs release from adipose tissue constitutes the major energy source and is maximal. Glucocorticoids increase hepatic lipogenesis and secretion <xref rid="B48" ref-type="bibr">(48</xref><xref rid="B49" ref-type="bibr">49</xref><xref rid="B50" ref-type="bibr">50)</xref>. Furthermore, the consequences of altered glucocorticoid status on hepatic triglyceride metabolism are dependent on diet composition <xref rid="B51" ref-type="bibr">(51)</xref>, but only when the diet is fed <italic>ad libitum</italic><xref rid="B52" ref-type="bibr">(52)</xref>. Thus, if lipid flux is low, when animals are maintained on an LF diet or with the restricted HF diet, then glucocorticoids minimally affect hepatic triglyceride storage and secretion <xref rid="B52" ref-type="bibr">(52)</xref>. Whether the increased hepatic triglyceride levels in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice are a consequence of the elevated peak corticosterone levels in these mice (morning levels did not differ after the HF diet) or a direct consequence of reduced hepatic GR density remains to be determined. 11&#x003b2;-HSD1 levels are unlikely to contribute to elevated hepatic triglycerides, since adipose or liver mRNA levels were unaltered (unpublished observations).</p><p>Blood pressure was increased by the HF diet in both genotypes, consistent with previous data <xref rid="B36" ref-type="bibr">(36</xref><xref rid="B37" ref-type="bibr">, 37</xref><xref rid="B53" ref-type="bibr">, 53)</xref>. However, the magnitude of the HF-induced increase in blood pressure was smaller in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice so that blood pressure in HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice did not differ from that in HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice. The mechanism underlying the blood pressure increase with the HF diet remains unclear but may differ between genotypes. In <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, further RAAS activation may contribute. Plasma angiotensinogen levels were increased by the HF diet in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice, probably as a result of increased hepatic expression of angiotensinogen, but were unaffected in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice in which the diet-induced increase in blood pressure was greater. The HF diet had no effect on plasma aldosterone levels or plasma renin activity in either genotype. Thus, activation of the systemic RAAS by the HF diet in <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice is ruled out. Elevated plasma glucocorticoid levels drive hypertension in both humans and rodents <xref rid="B1" ref-type="bibr">(1</xref><xref rid="B54" ref-type="bibr">, 54)</xref>. However, the underlying mechanisms remain controversial but are likely to include changes in the sympathetic nervous system. In this regard, it is of note that adrenal catecholamines, implicated in the HF diet-induced hypertension <xref rid="B53" ref-type="bibr">(53)</xref>, are reduced in <italic>GR</italic><sup>&#x0002b;/&#x02212;</sup> mice <xref rid="B11" ref-type="bibr">(11</xref><xref rid="B34" ref-type="bibr">, 34)</xref>. It will be of interest, in future work, to determine whether sympathetic nervous system activity is altered in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice.</p><p>In humans, polymorphisms in the <italic>GR</italic> gene associated with hypersensitivity or hyposensitivity to glucocorticoids in a dexamethasone suppression test have been variably associated with differences in body mass index, waist-hip ratio, altered body composition, and metabolic parameters (reviewed in ref. <xref rid="B14" ref-type="bibr">14</xref>) as well as differences in blood pressure <xref rid="B55" ref-type="bibr">(55</xref><xref rid="B56" ref-type="bibr">56</xref><xref rid="B57" ref-type="bibr">57</xref><xref rid="B58" ref-type="bibr">58</xref><xref rid="B59" ref-type="bibr">59)</xref>. However, the association studies <xref rid="B14" ref-type="bibr">(14)</xref> are controversial and may depend on age, gender, and ethnic background. The data reported here provide insights into that heterogeneity. In our model of glucocorticoid resistance due to &#x0223c;50% reduction in GR density, the observed physiological differences between genotypes depend on environment. Thus, several of the differences between genotypes are abolished or reduced after the HF diet. If the same applies in humans, then (for example) obesity or other chronic stress may mask differences in blood pressure between populations with different <italic>GR</italic> polymorphisms.</p><p>Glucocorticoids form part of important homeostatic control mechanisms that are critical in adapting to environmental challenges. Thus, they maintain stability through change over time (allostasis; reviewed in refs. <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>). <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice do not show the normal adaptions to the HF diet; they have an attenuated blood pressure response and do not show the alterations in adrenal size and HPA axis activity seen in WT mice. Consequently, basal corticosterone levels are normalized between genotypes after the HF diet. Moreover, <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice accumulated more hepatic triglyceride, possibly because of inadequate adaption to excessive dietary fat/energy intake and the need to protect vital organs. Continued excessive lipid accumulation in the liver may, in turn, lead to insulin resistance and metabolic disease. GR density is likely to be limiting in other systems in adaption to environmental stressors. Mice heterozygous for inactivating mutations in <italic>GR</italic> show reduced coping behavior in a mouse correlate of depression, with compromised indicators of neural plasticity <xref rid="B40" ref-type="bibr">(40)</xref>, whereas overexpression of GR results in resistance to stress and robust protection against endotoxins. These adaptive or &#x0201c;remodeling&#x0201d; effects of glucocorticoids in the adult response to the HF diet are reminiscent of the prenatal &#x0201c;programming&#x0201d; effects of glucocorticoids (reviewed in ref. <xref rid="B62" ref-type="bibr">62</xref>) where exposure of the late fetus to glucocorticoids permanently programs tissue systems throughout life, including blood pressure, glucose/lipid homeostasis, and tissue GR density itself. It will be of great interest to determine whether GR density influences the prenatal programming effects of glucocorticoids in the same way that it alters the postnatal blood pressure and HPA adaptions to a chronic HF diet.</p></sec></body><back><ack><p>We thank Mark Danielsen (Georgetown University School of Medicine, Washington, DC, USA) for kindly providing the SV2wrec plasmid encoding mouse GR cDNA and David Pearce (University of California, San Francisco, Department of Medicine, San Francisco, CA, USA) for providing the rPNMT-998/-466 Luc plasmid. We thank the Biomedical Research Resources facility, University of Edinburgh, facility for assistance with animal care and members of the Endocrinology Unit for helpful discussions and advice. This work was supported by a Wellcome Trust PhD Studentship (to Z.M.), a British Heart Foundation Project Grant (to K.E.C., C.J.K., N.M.M., and J.R.S.), a Wellcome Trust Programme Grant (to J.R.S. and K.E.C.), a Wellcome Trust Project Grant (to M.C.H and J.R.S.), and a Medical Research Council Programme Grant (to C.J.K.). N.M.M. is supported by a Wellcome Trust Research Career Development Fellowship.</p></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitworth</surname><given-names>J A</given-names></name><name><surname>Brown</surname><given-names>M A</given-names></name><name><surname>Kelly</surname><given-names>J J</given-names></name><name><surname>Williamson</surname><given-names>P M</given-names></name></person-group><article-title>Mechanisms of cortisol-induced hypertension in humans</article-title><source>Steroids</source><volume>60</volume><year>1995</year><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">7792821</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dallman</surname><given-names>M F</given-names></name><name><surname>Strack</surname><given-names>A M</given-names></name><name><surname>Akana</surname><given-names>S F</given-names></name><name><surname>Bradbury</surname><given-names>M J</given-names></name><name><surname>Hanson</surname><given-names>E S</given-names></name><name><surname>Scribner</surname><given-names>K A</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name></person-group><article-title>Feast and famine&#x02013;critical role of glucocorticoids with insulin in daily energy-flow</article-title><source>Front Neuroendocrinol</source><volume>14</volume><year>1993</year><fpage>303</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">8258378</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>P L</given-names></name><name><surname>Baxter</surname><given-names>J D</given-names></name><name><surname>Higgins</surname><given-names>S J</given-names></name><name><surname>Rousseau</surname><given-names>G G</given-names></name><name><surname>Tomkins</surname><given-names>G M</given-names></name></person-group><article-title>General presence of glucocorticoid receptors in mammalian tissues</article-title><source>Endocrinology</source><volume>94</volume><year>1974</year><fpage>998</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">4362047</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollenberg</surname><given-names>S M</given-names></name><name><surname>Weinberger</surname><given-names>C</given-names></name><name><surname>Ong</surname><given-names>E S</given-names></name><name><surname>Cerelli</surname><given-names>G</given-names></name><name><surname>Oro</surname><given-names>A</given-names></name><name><surname>Lebo</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>E B</given-names></name><name><surname>Rosenfeld</surname><given-names>M G</given-names></name><name><surname>Evans</surname><given-names>R M</given-names></name></person-group><article-title>Primary structure and expression of a functional human glucocorticoid receptor cDNA</article-title><source>Nature</source><volume>318</volume><year>1985</year><fpage>635</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">2867473</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miesfeld</surname><given-names>R</given-names></name><name><surname>Rusconi</surname><given-names>S</given-names></name><name><surname>Godowski</surname><given-names>P J</given-names></name><name><surname>Maler</surname><given-names>B A</given-names></name><name><surname>Okret</surname><given-names>S</given-names></name><name><surname>Wikstr&#x000f6;m</surname><given-names>A C</given-names></name><name><surname>Gustafsson</surname><given-names>J-&#x000c5;</given-names></name><name><surname>Yamamoto</surname><given-names>K R</given-names></name></person-group><article-title>Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cdna</article-title><source>Cell</source><volume>46</volume><year>1986</year><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">3755378</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangelsdorf</surname><given-names>D J</given-names></name><name><surname>Thummel</surname><given-names>C</given-names></name><name><surname>Beato</surname><given-names>M</given-names></name><name><surname>Herrlich</surname><given-names>P</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Umesono</surname><given-names>K</given-names></name><name><surname>Blumberg</surname><given-names>B</given-names></name><name><surname>Kastner</surname><given-names>P</given-names></name><name><surname>Mark</surname><given-names>M</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>R M</given-names></name></person-group><article-title>The nuclear receptor superfamily: the second decade</article-title><source>Cell</source><volume>83</volume><year>1995</year><fpage>835</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">8521507</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanderbilt</surname><given-names>J N</given-names></name><name><surname>Miesfeld</surname><given-names>R</given-names></name><name><surname>Maler</surname><given-names>B A</given-names></name><name><surname>Yamamoto</surname><given-names>K R</given-names></name></person-group><article-title>Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity</article-title><source>Mol Endocrinol</source><volume>1</volume><year>1987</year><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">2842660</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramdas</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Harmon</surname><given-names>J M</given-names></name></person-group><article-title>Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells</article-title><source>Cancer Res</source><volume>59</volume><year>1999</year><fpage>1378</fpage><lpage>1385</lpage><pub-id pub-id-type="pmid">10096574</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reichardt</surname><given-names>H M</given-names></name><name><surname>Umland</surname><given-names>T</given-names></name><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Kretz</surname><given-names>O</given-names></name><name><surname>Sch&#x000fc;tz</surname><given-names>G</given-names></name></person-group><article-title>Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock</article-title><source>Mol Cell Biol</source><volume>20</volume><year>2000</year><fpage>9009</fpage><lpage>9017</lpage><pub-id pub-id-type="pmid">11073999</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pazirandeh</surname><given-names>A</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Prestegaard</surname><given-names>T</given-names></name><name><surname>Jondal</surname><given-names>M</given-names></name><name><surname>Okret</surname><given-names>S</given-names></name></person-group><article-title>Effects of altered glucocorticoid sensitivity in the T-cell lineage on thymocyte and T-cell homeostasis</article-title><source>FASEB J</source><volume>16</volume><year>2002</year><fpage>727</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">11923224</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>T J</given-names></name><name><surname>Blendy</surname><given-names>J A</given-names></name><name><surname>Monaghan</surname><given-names>A P</given-names></name><name><surname>Krieglstein</surname><given-names>K</given-names></name><name><surname>Schmid</surname><given-names>W</given-names></name><name><surname>Aguzzi</surname><given-names>A</given-names></name><name><surname>Fantuzzi</surname><given-names>G</given-names></name><name><surname>Hummler</surname><given-names>E</given-names></name><name><surname>Unsicker</surname><given-names>K</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name></person-group><article-title>Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation</article-title><source>Genes Dev</source><volume>9</volume><year>1995</year><fpage>1608</fpage><lpage>1621</lpage><pub-id pub-id-type="pmid">7628695</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Reichardt</surname><given-names>H M</given-names></name><name><surname>Sch&#x000fc;tz</surname><given-names>G</given-names></name></person-group><article-title>Genetic dissection of glucocorticoid receptor function in mice</article-title><source>Curr Opin Genet Dev</source><volume>8</volume><year>1998</year><fpage>532</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">9794823</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kino</surname><given-names>T</given-names></name><name><surname>Chrousos</surname><given-names>G P</given-names></name></person-group><article-title>Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes</article-title><source>J Endocrinol</source><volume>169</volume><year>2001</year><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">11375113</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Rossum</surname><given-names>E F</given-names></name><name><surname>Lamberts</surname><given-names>S W</given-names></name></person-group><article-title>Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition</article-title><source>Recent Prog Horm Res</source><volume>59</volume><year>2004</year><fpage>333</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">14749509</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gass</surname><given-names>P</given-names></name><name><surname>Reichardt</surname><given-names>H M</given-names></name><name><surname>Strekalova</surname><given-names>T</given-names></name><name><surname>Henn</surname><given-names>F</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name></person-group><article-title>Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety?</article-title><source>Physiol Behav</source><volume>73</volume><year>2001</year><fpage>811</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">11566214</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>M P</given-names></name><name><surname>Muglia</surname><given-names>L J</given-names></name></person-group><article-title>Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice</article-title><source>Front Neuroendocrinol</source><volume>27</volume><year>2006</year><fpage>275</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">16814372</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleiman</surname><given-names>A</given-names></name><name><surname>Tuckermann</surname><given-names>J P</given-names></name></person-group><article-title>Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice</article-title><source>Mol Cell Endocrinol</source><volume>275</volume><year>2007</year><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">17587493</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pepin</surname><given-names>M-C</given-names></name><name><surname>Pothier</surname><given-names>F</given-names></name><name><surname>Barden</surname><given-names>N</given-names></name></person-group><article-title>Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene</article-title><source>Nature</source><volume>355</volume><year>1992</year><fpage>725</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">1741058</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>D</given-names></name><name><surname>Chapdelaine</surname><given-names>S</given-names></name><name><surname>Deshaies</surname><given-names>Y</given-names></name><name><surname>Pepin</surname><given-names>M C</given-names></name><name><surname>Barden</surname><given-names>N</given-names></name></person-group><article-title>Energy balance and lipid metabolism in transgenic mice bearing an antisense GCR gene construct</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>265</volume><year>1993</year><fpage>R146</fpage><lpage>R150</lpage></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Eiden</surname><given-names>S</given-names></name><name><surname>Kretz</surname><given-names>O</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Simon</surname><given-names>E</given-names></name></person-group><article-title>Inactivation of the GR in the nervous system affects energy accumulation</article-title><source>Endocrinology</source><volume>143</volume><year>2002</year><fpage>2333</fpage><lpage>2340</lpage><pub-id pub-id-type="pmid">12021198</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Opherk</surname><given-names>C</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Kohlmuller</surname><given-names>D</given-names></name><name><surname>Schulze</surname><given-names>A</given-names></name><name><surname>Schmid</surname><given-names>W</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name></person-group><article-title>Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus</article-title><source>Mol Endocrinol</source><volume>18</volume><year>2004</year><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">15031319</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sainte-Marie</surname><given-names>Y</given-names></name><name><surname>Nguyen Dinh Cat</surname><given-names>A</given-names></name><name><surname>Perrier</surname><given-names>R</given-names></name><name><surname>Mangin</surname><given-names>L</given-names></name><name><surname>Soukaseum</surname><given-names>C</given-names></name><name><surname>Peuchmaur</surname><given-names>M</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Farman</surname><given-names>N</given-names></name><name><surname>Escoubet</surname><given-names>B</given-names></name><name><surname>Benitah</surname><given-names>J P</given-names></name><name><surname>Jaisser</surname><given-names>F</given-names></name></person-group><article-title>Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block</article-title><source>FASEB J</source><volume>21</volume><year>2007</year><fpage>3133</fpage><lpage>3141</lpage><pub-id pub-id-type="pmid">17517920</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>H G</given-names></name><name><surname>Mumford</surname><given-names>G K</given-names></name><name><surname>Newton</surname><given-names>K</given-names></name><name><surname>Ford</surname><given-names>L V</given-names></name><name><surname>Farrall</surname><given-names>R</given-names></name><name><surname>Dellaire</surname><given-names>G</given-names></name><name><surname>Caceres</surname><given-names>J F</given-names></name><name><surname>Bickmore</surname><given-names>W A</given-names></name></person-group><article-title>Large-scale identification of mammalian proteins localized to nuclear sub-compartments</article-title><source>Hum Mol Genet</source><volume>10</volume><year>2001</year><fpage>1995</fpage><lpage>2011</lpage><pub-id pub-id-type="pmid">11555636</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>H J</given-names></name><name><surname>Kotelevtsev</surname><given-names>Y</given-names></name><name><surname>Mullins</surname><given-names>J J</given-names></name><name><surname>Seckl</surname><given-names>J R</given-names></name><name><surname>Holmes</surname><given-names>M C</given-names></name></person-group><article-title>Intracellular regeneration of glucocorticoids by 11b-hydroxysteroid dehydrogenase (11b-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11b-HSD-1 deficient mice</article-title><source>Endocrinology</source><volume>142</volume><year>2001</year><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">11145573</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>N M</given-names></name><name><surname>Densmore</surname><given-names>V</given-names></name><name><surname>Wamil</surname><given-names>M</given-names></name><name><surname>Ramage</surname><given-names>L</given-names></name><name><surname>Nichol</surname><given-names>K</given-names></name><name><surname>Bunger</surname><given-names>L</given-names></name><name><surname>Seckl</surname><given-names>J R</given-names></name><name><surname>Kenyon</surname><given-names>C J</given-names></name></person-group><article-title>A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action</article-title><source>Diabetes</source><volume>54</volume><year>2005</year><fpage>3371</fpage><lpage>3378</lpage><pub-id pub-id-type="pmid">16306351</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Dujaili</surname><given-names>E A</given-names></name><name><surname>Edwards</surname><given-names>C R</given-names></name></person-group><article-title>Development and application of a simple radioimmunoassay for urinary aldosterone</article-title><source>Clin Chim Acta</source><volume>116</volume><year>1981</year><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">7296892</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Dujaili</surname><given-names>E A</given-names></name></person-group><article-title>Development and validation of a simple and direct ELISA method for the determination of conjugated (glucuronide) and non-conjugated testosterone excretion in urine</article-title><source>Clin Chim Acta</source><volume>364</volume><year>2006</year><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">16098502</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>A L</given-names></name><name><surname>Brown</surname><given-names>W</given-names></name><name><surname>Kenyon</surname><given-names>C J</given-names></name><name><surname>Maxted</surname><given-names>K J</given-names></name><name><surname>Smith</surname><given-names>D C</given-names></name></person-group><article-title>Improved system for measuring systolic blood pressure in the conscious rat</article-title><source>Med Biol Eng Comput</source><volume>32</volume><year>1994</year><fpage>101</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">8182951</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seckl</surname><given-names>J R</given-names></name><name><surname>Dickson</surname><given-names>K L</given-names></name><name><surname>Fink</surname><given-names>G</given-names></name></person-group><article-title>Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression</article-title><source>J Neuroendocrinol</source><volume>2</volume><year>1990</year><fpage>911</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">19215437</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefebvre</surname><given-names>P</given-names></name><name><surname>Barard</surname><given-names>D S</given-names></name><name><surname>Cordingley</surname><given-names>M G</given-names></name><name><surname>Hager</surname><given-names>G L</given-names></name></person-group><article-title>Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines</article-title><source>Mol Cell Biol</source><volume>11</volume><year>1991</year><fpage>2529</fpage><lpage>2537</lpage><pub-id pub-id-type="pmid">1708094</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M</given-names></name><name><surname>Meijer</surname><given-names>O C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bhargava</surname><given-names>A</given-names></name><name><surname>Pearce</surname><given-names>D</given-names></name></person-group><article-title>Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants</article-title><source>Mol Endocrinol</source><volume>17</volume><year>2003</year><fpage>2583</fpage><lpage>2592</lpage><pub-id pub-id-type="pmid">12933902</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danielsen</surname><given-names>M</given-names></name><name><surname>Northrop</surname><given-names>J P</given-names></name><name><surname>Ringold</surname><given-names>G M</given-names></name></person-group><article-title>The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins</article-title><source>EMBO J</source><volume>5</volume><year>1986</year><fpage>2513</fpage><lpage>2522</lpage><pub-id pub-id-type="pmid">3780669</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasai</surname><given-names>Y</given-names></name></person-group><article-title>Two naturally-occurring isoforms and their expression of a glucocorticoid receptor gene from an androgen-dependent mouse tumor</article-title><source>FEBS Lett</source><volume>274</volume><year>1990</year><fpage>99</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">2253790</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Finotto</surname><given-names>S</given-names></name><name><surname>Krieglstein</surname><given-names>K</given-names></name><name><surname>Schober</surname><given-names>A</given-names></name><name><surname>Deimling</surname><given-names>F</given-names></name><name><surname>Lindner</surname><given-names>K</given-names></name><name><surname>Bruhl</surname><given-names>B</given-names></name><name><surname>Beier</surname><given-names>K</given-names></name><name><surname>Metz</surname><given-names>J</given-names></name><name><surname>Garcia-Arraras</surname><given-names>J E</given-names></name><name><surname>Roig-Lopez</surname><given-names>J L</given-names></name><name><surname>Monaghan</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>W</given-names></name><name><surname>Cole</surname><given-names>T J</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Unsicker</surname><given-names>K</given-names></name></person-group><article-title>Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells</article-title><source>Development</source><volume>126</volume><year>1999</year><fpage>2935</fpage><lpage>2944</lpage><pub-id pub-id-type="pmid">10357937</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tannenbaum</surname><given-names>B M</given-names></name><name><surname>Brindley</surname><given-names>D N</given-names></name><name><surname>Tannenbaum</surname><given-names>G S</given-names></name><name><surname>Dallman</surname><given-names>M F</given-names></name><name><surname>McArthur</surname><given-names>M D</given-names></name><name><surname>Meaney</surname><given-names>M J</given-names></name></person-group><article-title>High-fat feeding alters both basal and stress-induced hypothalamic- pituitary-adrenal activity in the rat</article-title><source>Am J Physiol Endocrinol Metab</source><volume>273</volume><year>1997</year><fpage>E1168</fpage><lpage>E1177</lpage></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>E</given-names></name><name><surname>Kuhn</surname><given-names>C M</given-names></name><name><surname>Feinglos</surname><given-names>M N</given-names></name><name><surname>Surwit</surname><given-names>R</given-names></name></person-group><article-title>Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>264</volume><year>1993</year><fpage>R73</fpage><lpage>R78</lpage></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>T D</given-names></name><name><surname>Chambers</surname><given-names>J B</given-names></name><name><surname>Roberts</surname><given-names>L M</given-names></name><name><surname>Henderson</surname><given-names>R P</given-names></name><name><surname>Overton</surname><given-names>J M</given-names></name></person-group><article-title>Diet-induced obesity and cardiovascular regulation in C57BL/6J mice</article-title><source>Clin Exp Pharmacol Physiol</source><volume>30</volume><year>2003</year><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">14516417</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frederich</surname><given-names>R C</given-names><suffix>Jr</suffix></name><name><surname>Kahn</surname><given-names>B B</given-names></name><name><surname>Peach</surname><given-names>M J</given-names></name><name><surname>Flier</surname><given-names>J S</given-names></name></person-group><article-title>Tissue-specific nutritional regulation of angiotensinogen in adipose tissue</article-title><source>Hypertension</source><volume>19</volume><year>1992</year><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">1555865</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seckl</surname><given-names>J R</given-names></name><name><surname>Brown</surname><given-names>R W</given-names></name></person-group><article-title>11&#x003b2;-hydroxysteroid dehydrogenase: on several roads to hypertension</article-title><source>J Hypertension</source><volume>12</volume><year>1994</year><fpage>105</fpage><lpage>112</lpage></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ridder</surname><given-names>S</given-names></name><name><surname>Chourbaji</surname><given-names>S</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><name><surname>Urani</surname><given-names>A</given-names></name><name><surname>Zacher</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>W</given-names></name><name><surname>Zink</surname><given-names>M</given-names></name><name><surname>Hortnagl</surname><given-names>H</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><name><surname>Henn</surname><given-names>F A</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Gass</surname><given-names>P</given-names></name></person-group><article-title>Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions</article-title><source>J Neurosci</source><volume>25</volume><year>2005</year><fpage>6243</fpage><lpage>6250</lpage><pub-id pub-id-type="pmid">15987954</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yau</surname><given-names>J L</given-names></name><name><surname>Noble</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Kerwin</surname><given-names>R</given-names></name><name><surname>Morgan</surname><given-names>P E</given-names></name><name><surname>Lightman</surname><given-names>S</given-names></name><name><surname>Seckl</surname><given-names>J R</given-names></name><name><surname>Pariante</surname><given-names>C M</given-names></name></person-group><article-title>The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice</article-title><source>Neuropsychopharmacology</source><volume>32</volume><year>2007</year><fpage>2520</fpage><lpage>2529</lpage><pub-id pub-id-type="pmid">17356567</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Kretz</surname><given-names>O</given-names></name><name><surname>Gass</surname><given-names>P</given-names></name><name><surname>Anlag</surname><given-names>K</given-names></name><name><surname>Orban</surname><given-names>P C</given-names></name><name><surname>Bock</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name></person-group><article-title>Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety</article-title><source>Nat Genet</source><volume>23</volume><year>1999</year><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">10471508</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kino</surname><given-names>T</given-names></name><name><surname>Vottero</surname><given-names>A</given-names></name><name><surname>Charmandari</surname><given-names>E</given-names></name><name><surname>Chrousos</surname><given-names>G P</given-names></name></person-group><article-title>Familial/sporadic glucocorticoid resistance syndrome and hypertension</article-title><source>Ann N Y Acad Sci</source><volume>970</volume><year>2002</year><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">12381545</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Soubrier</surname><given-names>F</given-names></name><name><surname>Menard</surname><given-names>J</given-names></name><name><surname>Panthier</surname><given-names>J J</given-names></name><name><surname>Rougeon</surname><given-names>F</given-names></name><name><surname>Corvol</surname><given-names>P</given-names></name></person-group><article-title>Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA</article-title><source>Hypertension</source><volume>7</volume><year>1985</year><fpage>855</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">3908312</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>M P</given-names></name><name><surname>Brewer</surname><given-names>J A</given-names></name><name><surname>Funatsu</surname><given-names>M</given-names></name><name><surname>Wozniak</surname><given-names>D F</given-names></name><name><surname>Tsien</surname><given-names>J Z</given-names></name><name><surname>Izumi</surname><given-names>Y</given-names></name><name><surname>Muglia</surname><given-names>L J</given-names></name></person-group><article-title>Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><year>2005</year><fpage>473</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">15623560</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coll</surname><given-names>A P</given-names></name><name><surname>Challis</surname><given-names>B G</given-names></name><name><surname>Yeo</surname><given-names>G S</given-names></name><name><surname>Snell</surname><given-names>K</given-names></name><name><surname>Piper</surname><given-names>S J</given-names></name><name><surname>Halsall</surname><given-names>D</given-names></name><name><surname>Thresher</surname><given-names>R R</given-names></name><name><surname>O'Rahilly</surname><given-names>S</given-names></name></person-group><article-title>The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin</article-title><source>Endocrinology</source><volume>145</volume><year>2004</year><fpage>4721</fpage><lpage>4727</lpage><pub-id pub-id-type="pmid">15231703</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>K K</given-names></name><name><surname>Noble</surname><given-names>R L</given-names></name></person-group><article-title>Effects of feeding rape oil on some endocrine functions of the rat</article-title><source>Endocrinology</source><volume>51</volume><year>1952</year><fpage>476</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">13021094</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klausner</surname><given-names>H</given-names></name><name><surname>Heimberg</surname><given-names>M</given-names></name></person-group><article-title>Effect of adrenalcortical hormones on release of triglycerides and glucose by liver</article-title><source>Am J Physiol</source><volume>212</volume><year>1967</year><fpage>1236</fpage><lpage>1246</lpage><pub-id pub-id-type="pmid">4952109</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirk</surname><given-names>C J</given-names></name><name><surname>Verrinder</surname><given-names>T R</given-names></name><name><surname>Hems</surname><given-names>D A</given-names></name></person-group><article-title>Fatty acid synthesis in the perfused liver of adrenalectomized rats</article-title><source>Biochem J</source><volume>156</volume><year>1976</year><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">949341</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>S M</given-names></name><name><surname>Gibbons</surname><given-names>G F</given-names></name></person-group><article-title>Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin</article-title><source>Biochem J</source><volume>249</volume><year>1988</year><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">3277620</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantha</surname><given-names>L</given-names></name><name><surname>Palacios</surname><given-names>E</given-names></name><name><surname>Deshaies</surname><given-names>Y</given-names></name></person-group><article-title>Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>277</volume><year>1999</year><fpage>R455</fpage><lpage>R464</lpage></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mantha</surname><given-names>L</given-names></name><name><surname>Deshaies</surname><given-names>Y</given-names></name></person-group><article-title>Energy intake-independent modulation of triglyceride metabolism by glucocorticoids in the rat</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>278</volume><year>2000</year><fpage>R1424</fpage><lpage>R1432</lpage><pub-id pub-id-type="pmid">10848507</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>L N</given-names></name><name><surname>Li</surname><given-names>H Y</given-names></name><name><surname>Peterson</surname><given-names>M M</given-names></name><name><surname>Gilardy</surname><given-names>A K</given-names></name></person-group><article-title>Adrenal medulla as a mediator of diet-induced hypertension</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>265</volume><year>1993</year><fpage>R1</fpage><lpage>R6</lpage></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magiakou</surname><given-names>M A</given-names></name><name><surname>Smyrnaki</surname><given-names>P</given-names></name><name><surname>Chrousos</surname><given-names>G P</given-names></name></person-group><article-title>Hypertension in Cushing&#x02019;s syndrome</article-title><source>Best Pract Res Clin Endocrinol Metab</source><volume>20</volume><year>2006</year><fpage>467</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">16980206</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>G C</given-names></name><name><surname>Harrap</surname><given-names>S B</given-names></name><name><surname>Foy</surname><given-names>C J</given-names></name><name><surname>Holton</surname><given-names>D W</given-names></name><name><surname>Edwards</surname><given-names>H V</given-names></name><name><surname>Davidson</surname><given-names>H R</given-names></name><name><surname>Connor</surname><given-names>J M</given-names></name><name><surname>Lever</surname><given-names>A F</given-names></name><name><surname>Fraser</surname><given-names>R</given-names></name></person-group><article-title>Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure</article-title><source>J Hypertens</source><volume>10</volume><year>1992</year><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">1350793</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panarelli</surname><given-names>M</given-names></name><name><surname>Holloway</surname><given-names>C D</given-names></name><name><surname>Fraser</surname><given-names>R</given-names></name><name><surname>Connell</surname><given-names>J M C</given-names></name><name><surname>Ingram</surname><given-names>M C</given-names></name><name><surname>Anderson</surname><given-names>N H</given-names></name><name><surname>Kenyon</surname><given-names>C J</given-names></name></person-group><article-title>Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects</article-title><source>J Clin Endocrinol Metab</source><volume>83</volume><year>1998</year><fpage>1846</fpage><lpage>1852</lpage><pub-id pub-id-type="pmid">9626107</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takami</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>Z Y</given-names></name><name><surname>Stebbing</surname><given-names>M</given-names></name><name><surname>Harrap</surname><given-names>S B</given-names></name></person-group><article-title>Linkage analysis of glucocorticoid and beta2-adrenergic receptor genes with blood pressure and body mass index</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>276</volume><year>1999</year><fpage>H1379</fpage><lpage>H1384</lpage></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosmond</surname><given-names>R</given-names></name><name><surname>Chagnon</surname><given-names>Y C</given-names></name><name><surname>Holm</surname><given-names>G</given-names></name><name><surname>Chagnon</surname><given-names>M</given-names></name><name><surname>P&#x000e9;russe</surname><given-names>L</given-names></name><name><surname>Lindell</surname><given-names>K</given-names></name><name><surname>Carlsson</surname><given-names>B</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Bj&#x000f6;rntorp</surname><given-names>P</given-names></name></person-group><article-title>A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary- adrenal axis</article-title><source>Obes Res</source><volume>8</volume><year>2000</year><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">10832763</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Blasio</surname><given-names>A M</given-names></name><name><surname>van Rossum</surname><given-names>E F</given-names></name><name><surname>Maestrini</surname><given-names>S</given-names></name><name><surname>Berselli</surname><given-names>M E</given-names></name><name><surname>Tagliaferri</surname><given-names>M</given-names></name><name><surname>Podesta</surname><given-names>F</given-names></name><name><surname>Koper</surname><given-names>J W</given-names></name><name><surname>Liuzzi</surname><given-names>A</given-names></name><name><surname>Lamberts</surname><given-names>S W</given-names></name></person-group><article-title>The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients</article-title><source>Clin Endocrinol (Oxf)</source><volume>59</volume><year>2003</year><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">12807506</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korte</surname><given-names>S M</given-names></name><name><surname>Koolhaas</surname><given-names>J M</given-names></name><name><surname>Wingfield</surname><given-names>J C</given-names></name><name><surname>McEwen</surname><given-names>B S</given-names></name></person-group><article-title>The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease</article-title><source>Neurosci Biobehav Rev</source><volume>29</volume><year>2005</year><fpage>3</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15652252</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>K E</given-names></name><name><surname>Seckl</surname><given-names>J R</given-names></name></person-group><article-title>11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function</article-title><source>Neurochem Res</source><year>2007</year></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seckl</surname><given-names>J R</given-names></name></person-group><article-title>Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms</article-title><source>Mol Cell Endocrinol</source><volume>185</volume><year>2001</year><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11738795</pub-id></citation></ref></ref-list></back><floats-wrap><fig position="float" id="F1"><label>Figure 1.</label><caption><p>The GR-&#x003b2;geo fusion protein is transcriptionally inactive. <italic>A</italic>) Schematic view of the functional domains of GR (top), exon structure of GR cDNA (middle), and predicted structure of the GR-&#x003b2;geo chimeric mRNA (bottom). The N-terminal domain (NTD) of GR is encoded by exon 2 (exon 1 is noncoding), the DNA binding domain (DBD) by exons 3&#x02013;4, and the ligand binding domain (LBD) by exons 5&#x02013;9. The &#x003b2;geo cassette replaces exons 4&#x02013;9. <italic>B</italic>, <italic>C</italic>) HEK293 cells were transiently transfected with WT mouse GR, GR-&#x003b2;geo, or &#x0201c;empty&#x0201d; vector together with MMTV LTR-luciferase (<italic>B</italic>) or PMNT-998/-466-luciferase (<italic>C</italic>) reporters and then incubated without (white bars) or with (black bars) 1 &#x003bc;M dexamethasone. Data are means &#x000b1; <sc>se</sc> of 3 independent experiments, each performed in triplicate. Values are expressed relative to vector, arbitrarily set to 1. &#x0002a;&#x0002a;&#x0002a;<italic>P</italic> &#x0003c; 0.001 <italic>vs</italic>. untreated mice. Note the log scale for promoter activity. A.U., arbitrary units.</p></caption><graphic xlink:href="z380110870900001"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have reduced GR mRNA levels in the brain, with normal distribution of GR-&#x003b2;geo expression. <italic>A</italic>) Representative X-gal stained <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> brain section showing strong staining in a pattern identical to GR mRNA distribution in hippocampal subfields CA1/2, dentate gyrus (DG), and paraventricular nucleus of the hypothalamus (PVN), with weaker staining in cortex and thalamus. <italic>B</italic>, <italic>C</italic>) Representative autoradiographs showing <italic>in situ</italic> hybridization of GR mRNA in brain coronal sections of <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (<italic>B</italic>) and GR<sup>&#x003b2;geo/&#x0002b;</sup> mice (<italic>C</italic>). <italic>D</italic>) Quantification of GR mRNA levels &#x0005b;optical density (OD)&#x0005d; in the PVN of <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> (white bars) and GR<sup>&#x003b2;geo/&#x0002b;</sup> mice (black bars) (<italic>n</italic>&#x0003d;6/group; &#x0002a;<italic>P</italic>&#x0003c;0.05).</p></caption><graphic xlink:href="z380110870900002"/></fig><table-wrap position="float" id="T1"><label>TABLE 1.</label><caption><p>GR<sup>&#x003b2;geo/&#x0002b;</sup> mice have half of the normal GR mRNA levels in the brain and peripheral tissues</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="2" align="left" valign="bottom">Tissue</th><th colspan="2" rowspan="1" align="center" valign="bottom">GR mRNA level (AU) <hr/></th><th colspan="1" rowspan="2" align="center" valign="bottom">Reduction (%)</th><th colspan="1" rowspan="2" align="center" valign="bottom"><italic>P</italic> value</th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Brain</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Hippocampus</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;CA1</td><td colspan="1" rowspan="1" align="center" valign="top">0.4 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;CA2</td><td colspan="1" rowspan="1" align="center" valign="top">0.5 &#x000b1; 0.06</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">60</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;CA3</td><td colspan="1" rowspan="1" align="center" valign="top">0.14 &#x000b1; 0.01</td><td colspan="1" rowspan="1" align="center" valign="top">0.06 &#x000b1; 0.02</td><td colspan="1" rowspan="1" align="center" valign="top">57</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;DG</td><td colspan="1" rowspan="1" align="center" valign="top">0.4 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;PVN</td><td colspan="1" rowspan="1" align="center" valign="top">0.4 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Pituitary</td><td colspan="1" rowspan="1" align="center" valign="top">0.5 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.04</td><td colspan="1" rowspan="1" align="center" valign="top">60</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Periphery</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Adrenal gland</td><td colspan="1" rowspan="1" align="center" valign="top">1.7 &#x000b1; 0.3</td><td colspan="1" rowspan="1" align="center" valign="top">0.6 &#x000b1; 0.08</td><td colspan="1" rowspan="1" align="center" valign="top">65</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Liver</td><td colspan="1" rowspan="1" align="center" valign="top">1.0 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">0.7 &#x000b1; 0.06</td><td colspan="1" rowspan="1" align="center" valign="top">30</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Epididymal fat</td><td colspan="1" rowspan="1" align="center" valign="top">1.3 &#x000b1; 0.09</td><td colspan="1" rowspan="1" align="center" valign="top">0.7 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">46</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0002</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Inguinal fat</td><td colspan="1" rowspan="1" align="center" valign="top">1.1 &#x000b1; 0.06</td><td colspan="1" rowspan="1" align="center" valign="top">0.6 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">45</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Mesenteric fat</td><td colspan="1" rowspan="1" align="center" valign="top">0.6 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">0.3 &#x000b1; 0.08</td><td colspan="1" rowspan="1" align="center" valign="top">50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;EDL muscle</td><td colspan="1" rowspan="1" align="center" valign="top">1.4 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.6 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">57</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.004</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Soleus muscle</td><td colspan="1" rowspan="1" align="center" valign="top">1.0 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.5 &#x000b1; 0.04</td><td colspan="1" rowspan="1" align="center" valign="top">50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td></tr></tbody></table><table-wrap-foot><fn><p>Levels of GR mRNA in brain were measured by <italic>in situ</italic> mRNA hybridization using a cRNA probe complementary to exons 5&#x02013;9 of GR, absent from mRNA encoding the GR-&#x003b2;geo fusion protein. Levels of full-length GR mRNA in peripheral tissues were measured by qPCR using a primer-probe set spanning exons 5&#x02013;6. Student&#x02019;s <italic>t</italic> test was performed for comparisons between genotypes (<italic>n</italic>&#x0003d;6/group). Significance was set at <italic>P</italic> &#x0003c; 0.05. AU, arbitrary units; CA, cornu ammonis; DG, dentate gyrus; PVN, paraventricular nucleus of the hypothalamus; EDL, extensor longus digitalis.&#x000a0;</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F3"><label>Figure 3.</label><caption><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have reduced functional GR protein levels. Representative Western blot analysis showing decreased normal GR (95 kDa) in epididymal fat of <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> (&#x0002b;/&#x02212;) mice compared with <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> (&#x0002b;/&#x0002b;) mice (top). The GR-&#x003b2;geo fusion protein (191 kDa) was apparent only in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. Tubulin (middle) and ponceau red staining (bottom) demonstrate equivalent protein loading.</p></caption><graphic xlink:href="z380110870900003"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p>HPA hyperactivity in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. <italic>A</italic>, <italic>B</italic>) Plasma corticosterone (cort) levels in LF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> (white bars), HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> (hatched bars), LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic></sup><sup>/&#x0002b;</sup> (black bars) and HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (gray bars) in the morning (<italic>A</italic>) and evening (<italic>B</italic>). <italic>C</italic>) Left adrenal weights in LF or HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> and <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<italic>n</italic>&#x0003d;8&#x02013;9/group). &#x0002a;<sup>,&#x02020;</sup><italic>P</italic> &#x0003c; 0.05; &#x0002a;&#x0002a;<italic>P</italic> &#x0003c; 0.01; <sup>&#x02020;&#x02020;&#x02020;</sup><italic>P</italic> &#x0003c; 0.001. &#x02021;<italic>P</italic> &#x0003c; 0.01 vs. HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice.</p></caption><graphic xlink:href="z380110870900004"/></fig><fig position="float" id="F5"><label>Figure 5.</label><caption><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have larger adrenal glands. Representative images of hematoxylin and eosin stained sections of adrenal glands from LF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (<italic>A</italic>, <italic>C</italic>); LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<italic>B</italic>, <italic>D</italic>); HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (<italic>E</italic>); and HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (<italic>F</italic>). ZF, zona fasciculate; ZG, zona glomerulosa; MED, medulla. <italic>n</italic> &#x0003d; 8&#x02013;9/group. Scale bars &#x0003d; 25 &#x003bc;m.</p></caption><graphic xlink:href="z380110870900005"/></fig><fig position="float" id="F6"><label>Figure 6.</label><caption><p>Unaltered body composition and glucose homeostasis in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice after HF diet. Body weight (<italic>A</italic>) and plasma glucose levels (<italic>B</italic>) after GTT in LF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (open squares, dashed line); HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (open circles, dashed line); LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (black squares, solid line) and HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (black circles, solid line) (<italic>n</italic>&#x0003d;6/group). &#x0002a;&#x0002a;&#x0002a;<italic>P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="z380110870900006"/></fig><table-wrap position="float" id="T2"><label>TABLE 2.</label><caption><p>Similar regional adiposity, lean mass, and plasma insulin and lipid levels in GR<sup>&#x003b2;geo/&#x0002b;</sup> and GR<sup>&#x0002b;/&#x0002b;</sup> mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="2" align="left" valign="bottom">Variable</th><th colspan="2" rowspan="1" align="center" valign="bottom">LF diet <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">HF diet <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Epididymal fat mass</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;% Body weight</td><td colspan="1" rowspan="1" align="center" valign="top">2.08 &#x000b1; 0.36</td><td colspan="1" rowspan="1" align="center" valign="top">1.66 &#x000b1; 0.38</td><td colspan="1" rowspan="1" align="center" valign="top">4.42 &#x000b1; 0.22<xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">4.90 &#x000b1; 0.38<xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Absolute wt (mg)</td><td colspan="1" rowspan="1" align="center" valign="top">657 &#x000b1; 140</td><td colspan="1" rowspan="1" align="center" valign="top">489 &#x000b1; 126</td><td colspan="1" rowspan="1" align="center" valign="top">1972 &#x000b1; 110</td><td colspan="1" rowspan="1" align="center" valign="top">2476 &#x000b1; 285</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Inguinal fat mass</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;% Body weight</td><td colspan="1" rowspan="1" align="center" valign="top">1.79 &#x000b1; 0.31</td><td colspan="1" rowspan="1" align="center" valign="top">1.36 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">4.22 &#x000b1; 0.27<xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">4.5 &#x000b1; 0.3.5<xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Absolute wt (mg)</td><td colspan="1" rowspan="1" align="center" valign="top">559 &#x000b1; 119</td><td colspan="1" rowspan="1" align="center" valign="top">387 &#x000b1; 23</td><td colspan="1" rowspan="1" align="center" valign="top">1914 &#x000b1; 186</td><td colspan="1" rowspan="1" align="center" valign="top">2230 &#x000b1; 274</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Mesenteric fat mass</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;% Body weight</td><td colspan="1" rowspan="1" align="center" valign="top">1.31 &#x000b1; 0.15</td><td colspan="1" rowspan="1" align="center" valign="top">1.07 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">2.16 &#x000b1; 0.13<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2.00 &#x000b1; 0.17<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Absolute wt (mg)</td><td colspan="1" rowspan="1" align="center" valign="top">408 &#x000b1; 67</td><td colspan="1" rowspan="1" align="center" valign="top">301 &#x000b1; 31</td><td colspan="1" rowspan="1" align="center" valign="top">979 &#x000b1; 92</td><td colspan="1" rowspan="1" align="center" valign="top">984 &#x000b1; 121</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Brown adipose mass</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;% Body weight</td><td colspan="1" rowspan="1" align="center" valign="top">0.38 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">0.38 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">0.62 &#x000b1; 0.05<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">0.79 &#x000b1; 0.05<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Absolute wt (mg)</td><td colspan="1" rowspan="1" align="center" valign="top">118 &#x000b1; 15</td><td colspan="1" rowspan="1" align="center" valign="top">107 &#x000b1; 8</td><td colspan="1" rowspan="1" align="center" valign="top">282 &#x000b1; 31</td><td colspan="1" rowspan="1" align="center" valign="top">381 &#x000b1; 34</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Muscle (EDL) mass</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;% Body weight</td><td colspan="1" rowspan="1" align="center" valign="top">0.24 &#x000b1; 0.02</td><td colspan="1" rowspan="1" align="center" valign="top">0.22 &#x000b1; 0.02</td><td colspan="1" rowspan="1" align="center" valign="top">0.16 &#x000b1; 0.01<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">0.15 &#x000b1; 0.01<xref rid="TFN2-2" ref-type="other">&#x0002a;&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;Absolute wt (mg)</td><td colspan="1" rowspan="1" align="center" valign="top">70.3 &#x000b1; 4</td><td colspan="1" rowspan="1" align="center" valign="top">60.8 &#x000b1; 5</td><td colspan="1" rowspan="1" align="center" valign="top">68.6 &#x000b1; 3</td><td colspan="1" rowspan="1" align="center" valign="top">68.8 &#x000b1; 3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Plasma insulin (ng/ml)</td><td colspan="1" rowspan="1" align="center" valign="top">0.2 &#x000b1; 0.01</td><td colspan="1" rowspan="1" align="center" valign="top">0.3 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.9 &#x000b1; 0.2<xref rid="TFN2-1" ref-type="other">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1.0 &#x000b1; 0.2<xref rid="TFN2-1" ref-type="other">&#x0002a;</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Plasma NEFA (mEq/l)</td><td colspan="1" rowspan="1" align="center" valign="top">0.8 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.6 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.65 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.8 &#x000b1; 0.1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Plasma TG (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">0.44 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">0.37 &#x000b1; 0.06</td><td colspan="1" rowspan="1" align="center" valign="top">0.52 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">0.47 &#x000b1; 0.04</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Liver TG (&#x003bc;mol/g)</td><td colspan="1" rowspan="1" align="center" valign="top">5.4 &#x000b1; 0.7</td><td colspan="1" rowspan="1" align="center" valign="top">8.0 &#x000b1; 1.6</td><td colspan="1" rowspan="1" align="center" valign="top">14.8 &#x000b1; 0.7<xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>18</italic>&#x000b1;<italic>0.8</italic><xref rid="TFN2-3" ref-type="other">&#x0002a;&#x0002a;&#x0002a;</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Plasma NEFA, plasma triglyceride (TG), and plasma insulin levels were measured after 24 h fast.&#x000a0;</p></fn><fn id="TFN2-1"><label>&#x0002a;</label><p><italic>P</italic> &#x0003c; 0.05;&#x000a0;</p></fn><fn id="TFN2-2"><label>&#x0002a;&#x0002a;</label><p><italic>P</italic> &#x0003c; 0.01;&#x000a0;</p></fn><fn id="TFN2-3"><label>&#x0002a;&#x0002a;&#x0002a;</label><p><italic>P</italic> &#x0003c; 0.001 vs. LF diet. Values in italics indicate a significant difference between genotypes. <italic>n</italic> &#x0003d; 8/group.&#x000a0;</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F7"><label>Figure 7.</label><caption><p><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice have elevated blood pressure. Systolic blood pressure (SBP) in LF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (white bars), HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (hatched bars), LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (black bars), and HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (gray bars). &#x0002a;<italic>P</italic> &#x0003c; 0.05; &#x0002a;&#x0002a;<sup>,&#x02020;&#x02020;</sup><italic>P</italic> &#x0003c; 0.01.</p></caption><graphic xlink:href="z380110870900007"/></fig><fig position="float" id="F8"><label>Figure 8.</label><caption><p>Activation of the RAAS in <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice. Plasma renin activity (<italic>A</italic>), plasma aldosterone concentration (<italic>B</italic>), plasma angiotensinogen concentration (<italic>C</italic>), epididymal fat angiotensinogen (AGT) mRNA levels (<italic>D</italic>), and hepatic AGT mRNA levels (<italic>E</italic>) in LF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (white bars), HF-fed <italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup> mice (hatched bars), LF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (black bars), and HF-fed <italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup> mice (gray bars). For plasma measurements, <italic>n</italic> &#x0003d; 5/group. For mRNA levels, <italic>n</italic> &#x0003d; 8&#x02013;9/group. &#x0002a;<sup>,&#x02020;</sup><italic>P</italic> &#x0003c; 0.05; &#x0002a;&#x0002a;<sup>,&#x02020;&#x02020;</sup><italic>P</italic> &#x0003c; 0.01; &#x0002a;&#x0002a;&#x0002a;<sup>,&#x02020;&#x02020;&#x02020;</sup><italic>P</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="z380110870900008"/></fig><table-wrap position="float" id="T3"><label>TABLE 3.</label><caption><p>Similar expression of mRNAs encoding renin, 11&#x003b2;-HSD2, and MR in GR<sup>&#x003b2;geo/&#x0002b;</sup> and GR<sup>&#x0002b;/&#x0002b;</sup> mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="2" align="left" valign="bottom">mRNA</th><th colspan="1" rowspan="2" align="center" valign="bottom">Tissue</th><th colspan="2" rowspan="1" align="center" valign="bottom">LF diet <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">HF diet <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x0002b;/&#x0002b;</sup></th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>GR</italic><sup>&#x003b2;<italic>geo</italic>/&#x0002b;</sup></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Renin</td><td colspan="1" rowspan="1" align="left" valign="top">Kidney</td><td colspan="1" rowspan="1" align="center" valign="top">0.87 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">0.95 &#x000b1; 0.20</td><td colspan="1" rowspan="1" align="center" valign="top">0.83 &#x000b1; 0.09</td><td colspan="1" rowspan="1" align="center" valign="top">0.75 &#x000b1; 0.06</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top">Adrenal</td><td colspan="1" rowspan="1" align="center" valign="top">0.98 &#x000b1; 0.20</td><td colspan="1" rowspan="1" align="center" valign="top">1.0 &#x000b1; 0.10</td><td colspan="1" rowspan="1" align="center" valign="top">ND</td><td colspan="1" rowspan="1" align="center" valign="top">ND</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">11&#x003b2;-HSD2</td><td colspan="1" rowspan="1" align="left" valign="top">Kidney</td><td colspan="1" rowspan="1" align="center" valign="top">0.85 &#x000b1; 0.03</td><td colspan="1" rowspan="1" align="center" valign="top">0.86 &#x000b1; 0.09</td><td colspan="1" rowspan="1" align="center" valign="top">0.94 &#x000b1; 0.04</td><td colspan="1" rowspan="1" align="center" valign="top">0.77 &#x000b1; 0.09</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">MR</td><td colspan="1" rowspan="1" align="left" valign="top">Kidney</td><td colspan="1" rowspan="1" align="center" valign="top">0.80 &#x000b1; 0.08</td><td colspan="1" rowspan="1" align="center" valign="top">0.96 &#x000b1; 0.20</td><td colspan="1" rowspan="1" align="center" valign="top">0.98 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">0.99 &#x000b1; 0.10</td></tr></tbody></table><table-wrap-foot><fn><p>Levels of specific mRNAs were measured by qPCR and are expressed in arbitrary units. There were no significant effects of either genotype or diet upon levels of any of the mRNAs measured (<italic>n</italic>&#x0003d;6/group).&#x000a0;</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 